Subsequent Events	6 Months Ended
Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 15 Subsequent Events On April 19, 2017, the Company’s Board of Directors authorized the Company to grant certain securities under the Company’s 2015 Incentive Plan, or any successor plan, consisting of, in the aggregate, options to purchase up to 2,150,000 shares of our common stock at exercise prices ranging from $3.00 per share to $5.00 per share, vesting on June 30, 2017, December 31, 2017, December 31, 2018 and December 31, 2019. As of June 30, 2017, the Company had not yet entered into award agreements with the grantees of such grants, and therefore had not issued options to purchase shares of the Company’s common stock pursuant to such grants. On August 2, 2017, the Company entered into Stock Option Agreements with two of the grantees thereby issuing, in the aggregate, options to purchase up to 350,000 shares of the Company’s common stock, with 175,000 of such options vested and having an exercise price of $3.00 per share and 175,000 of such options vesting on December 31, 2017 and having an exercise price of $4.00 per share. As of August 11, 2017, the Company had not yet entered into Stock Option Agreements with the other grantees.

Subsequent Events

6 Months Ended

Jun. 30, 2017

Note 15 Subsequent Events

On April 19, 2017, the Company’s Board of Directors authorized the Company to grant certain securities under the Company’s 2015 Incentive Plan, or any successor plan, consisting of, in the aggregate, options to purchase up to 2,150,000 shares of our common stock at exercise prices ranging from $3.00 per share to $5.00 per share, vesting on June 30, 2017, December 31, 2017, December 31, 2018 and December 31, 2019. As of June 30, 2017, the Company had not yet entered into award agreements with the grantees of such grants, and therefore had not issued options to purchase shares of the Company’s common stock pursuant to such grants. On August 2, 2017, the Company entered into Stock Option Agreements with two of the grantees thereby issuing, in the aggregate, options to purchase up to 350,000 shares of the Company’s common stock, with 175,000 of such options vested and having an exercise price of $3.00 per share and 175,000 of such options vesting on December 31, 2017 and having an exercise price of $4.00 per share. As of August 11, 2017, the Company had not yet entered into Stock Option Agreements with the other grantees.